Form 4: Avidity Biosciences Director Tamar Thompson Executes Stock Option and Sells Shares

Director Tamar Thompson exercised stock options and sold 30,000 shares of Avidity Biosciences (RNA) common stock on October 7, 2024.

Summary

• On October 7, 2024, Tamar Thompson, a director of Avidity Biosciences, exercised a stock option to purchase 30,000 shares of common stock at a price of $27.63 per share.
• Simultaneously, Thompson sold 30,000 shares of Avidity Biosciences common stock at a weighted-average price of $44.9753, with individual sales ranging from $44.20 to $45.57.
• Following these transactions, Thompson no longer directly owns any shares of Avidity Biosciences.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, although it is a common practice.
• The disclosure provides transparency to all stakeholders regarding insider trading activity.

Key Dates